| Mendenhall WM, Riggs CE, Vaysberg M, et al. Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma. [JOURNAL ARTICLE] Head Neck 2009 Nov 5. Abstract | Full Citation | Find Related Articles | | Ray M, Salgia R, Vokes EE The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer. [JOURNAL ARTICLE] Oncologist 2009 Nov 5. Abstract | Full Citation | Find Related Articles | | Nishiyama M, Wada S Docetaxel: its role in current and future treatments for advanced gastric cancer. [Journal Article] Gastric Cancer 2009; 12(3):132-41. Abstract | Full Citation | | Larbouret C, Robert B, Bascoul-Mollevi C, et al. Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts. [JOURNAL ARTICLE] Ann Oncol 2009 Nov 4. Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tai CJ, Hsu CH, Wang FJ, et al. Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer. [Letter] Onkologie 2009 Nov; 32(11):685-6. Full Citation | Find Related Articles | | Laurent-Puig P, Cayre A, Manceau G, et al. Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer. [JOURNAL ARTICLE] J Clin Oncol 2009 Nov 2. Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Smith RA, Yuan H, Weissleder R, et al. A Wortmannin-Cetuximab as a Double Drug. [JOURNAL ARTICLE] Bioconjug Chem 2009 Nov 2. Abstract | Full Citation | | Cleary JM, Tanabe KT, Lauwers GY, et al. Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver. [JOURNAL ARTICLE] Oncologist 2009 Oct 30. Abstract | Full Citation | Find Related Articles | | Kim R Cetuximab and panitumumab: are they interchangeable? [LETTER] Lancet Oncol 2009 Oct 27. Full Citation | Find Related Articles | | Paule B, Castagne V, Picard V, et al. MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer. [JOURNAL ARTICLE] Med Oncol 2009 Oct 28. Abstract | Full Citation | Find Related Articles |  |
|
| | Enter www.unboundmedicine.com/medline in your iPhone browser or View our Unbound MEDLINE iPhone demo Advertise on this site.
|